文献速递白血病

定量蛋白质组学揭示急性髓系白血病干细胞的特定代谢特征

Quantitative proteomics reveals specific metabolic features of acute myeloid leukemia stem cells.
PubMed 文献 · Blood · 2020-01-01

该研究将急性髓系白血病干细胞(LSC)的蛋白质组与年龄匹配的健康造血干/祖细胞(HSPC)及白血病原始细胞进行比较,并与转录组数据关联分析。研究发现LSC具有特征性的能量代谢、黏附分子组成及RNA加工特性,并验证了候选LSC标志物,突显了蛋白质组分析在检测代谢通路改变方面的优势。

要点

  • LSC蛋白质组与健康HSPC及白血病原始细胞比较,验证候选LSC标志物并发现HSPC中缺如或低表达的可靶向蛋白。
  • LSC具有特征性的能量代谢、黏附分子组成和RNA加工特性。
  • 同一标本的蛋白质组与转录组关联分析显示,蛋白质组分析在检测代谢通路改变方面尤为有力。

核心结论

  • 该研究提供了功能验证的LSC、原始细胞和健康HSPC的全面蛋白质组与转录组特征,为设计靶向LSC的治疗提供了宝贵资源。

研究设计与样本

  • 研究将LSC蛋白质组与年龄匹配的健康造血干/祖细胞(HSPC)进行比较,并将蛋白质组与相应转录组关联分析,同时比较LSC、白血病原始细胞和健康HSPC。

主要发现

  • 通过比较LSC与白血病原始细胞及健康HSPC,验证了候选LSC标志物,并突显了HSPC中缺如或低表达的新颖且潜在可靶向的蛋白质。
  • 数据提供强有力证据表明LSC具有特征性的能量代谢、黏附分子组成以及RNA加工特性。
  • 同一患者标本的蛋白质组与转录数据关联分析突显了蛋白质组分析的优势,尤其在检测代谢通路改变方面尤为有力。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Acute myeloid leukemia is characterized by the accumulation of clonal myeloid blast cells unable to differentiate into mature leukocytes. Chemotherapy induces remission in the majority of patients, but relapse rates are high and lead to poor clinical outcomes. Because this is primarily caused by chemotherapy-resistant leukemic stem cells (LSCs), it is essential to eradicate LSCs to improve patient survival. LSCs have predominantly been studied at the transcript level, thus information about posttranscriptionally regulated genes and associated networks is lacking. Here, we extend our previous report on LSC proteomes to healthy age-matched hematopoietic stem and progenitor cells (HSPCs) and correlate the proteomes to the corresponding transcriptomes. By comparing LSCs to leukemic blasts and healthy HSPCs, we validate candidate LSC markers and highlight novel and potentially targetable proteins that are absent or only lowly expressed in HSPCs. In addition, our data provide strong evidence that LSCs harbor a characteristic energy metabolism, adhesion molecule composition, as well as RNA-processing properties. Furthermore, correlating proteome and transcript data of the same individual samples highlights the strength of proteome analyses, which are particularly potent in detecting alterations in metabolic pathways. In summary, our study provides a comprehensive proteomic and transcriptomic characterization of functionally validated LSCs, blasts, and healthy HSPCs, representing a valuable resource helping to design LSC-directed therapies.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Raffel S, Klimmeck D, Falcone M, et al. Quantitative proteomics reveals specific metabolic features of acute myeloid leukemia stem cells. Blood. 2020. PMID: 32556243. doi:10.1182/blood.2019003654

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。